Of note, several studies have shown that IRF8 is involved in inhibiting multiple non-hematopoietic cancer cell growth and progression, indicating its potential tumor-suppressive activities [59,60] and its expression is regulated by DNA methylation [61,62]. Here, IRF8 is linked to cancer.